Showing results (211-220 of 625) with videos related to
Sort By:
Pageof 63
Plant Molecular Biology|October 1, 1995
Immunological evidence for accumulation of two high-molecular-weight (104 and 90 kDa) HSPs in response to different stresses in rice and in response to high temperature stress in diverse plant generaA Pareek, S L Singla, A GroverEpidemiology (Cambridge, Mass.)|July 16, 2003
Improving the prediction of cardiovascular risk: interaction between LDL and HDL cholesterolSteven A Grover, Marc Dorais, Louis CoupalThe Journal of Cell Biology|July 1, 1983
Role of laminin in epithelium formation by F9 aggregatesA Grover, G Andrews, E D AdamsonPhotosynthesis Research|January 18, 2014
Relative sensitivity of various spectral forms of photosynthetic pigments to leaf senescence in wheat (Triticum aestivum L.)A Grover, S C Sabat, P MohantyCarcinogenesis|August 1, 1994
Transformation-specific pattern of phosphorylation of c-Jun, Jun-B, Jun-D and Egr-1 in v-sis transformed cellsA Grover-Bardwick, E Adamson, D MercolaHypertension (Dallas, Tex. : 1979)|November 17, 2004
Treating osteoarthritis with cyclooxygenase-2-specific inhibitors: what are the benefits of avoiding blood pressure destabilization?Steven A Grover, Louis Coupal, Hanna ZowallAmerican Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|December 14, 2007
Estimating the cost effectiveness of ramipril used for specific clinical indications: comparing the outcomes in four clinical trials with a common economic modelSteven A Grover, Louis Coupal, Ilka LowensteynClinical and Experimental Immunology|April 21, 1999
Superantigen-induced T cell responses in acute rheumatic fever and chronic rheumatic heart disease patientsA Bhatnagar, A Grover, N K GangulyJournal of Clinical Epidemiology|February 11, 1999
Identifying adults at low risk for significant hyperlipidemia: a validated clinical indexS A Grover, C Levinton, S PaquetThe Canadian Journal of Cardiology|April 11, 2008
Determining the cost-effectiveness of preventing cardiovascular disease: are estimates calculated over the duration of a clinical trial adequate?Steven A Grover, Louis Coupal, Ilka LowensteynPageof 63